These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 14061061)

  • 1. NONCLASSICAL ANTIMETABOLITES. XVI. THE BRIDGE PRINCIPLE OF SPECIFICITY WITH ACTIVE SITE-DIRECTED IRREVERSIBLE INHIBITORS. VII. DETECTION OF DIFFERENCES IN SPECIFICITY OF ENZYMIC NUCLEOPHILIC SITES BY THE MALEAMYL GROUP.
    BAKER BR; ALUMAULA PI
    J Pharm Sci; 1963 Sep; 52():914-5. PubMed ID: 14061061
    [No Abstract]   [Full Text] [Related]  

  • 2. NONCLASSICAL ANTIMETABOLITES. XII. BRIDGE PRINCIPLE OF SPECIFICITY WITH EXO-ALKYLATING IRREVERSIBLE INHIBITORS. V. DIFFERENCES IN SPECIFICITY OF ENZYMIC NUCLEOPHILIC SITES AS DETECTED BY THE CARBOPHENOXY GROUP.
    BAKER BR; PATEL RP
    J Pharm Sci; 1963 Oct; 52():927-33. PubMed ID: 14076498
    [No Abstract]   [Full Text] [Related]  

  • 3. NONCLASSICAL ANTIMETABOLITES. XV. BRIDGE PRINCIPLE OF SPECIFICITY WITH ACTIVE-SITE-DIRECTED IRREVERSIBLE INHIBITORS. VI. HIGHLY SELECTIVE IRREVERSIBLE INHIBITION OF LACTIC DEHYDROGENASE.
    BAKER BR; PATEL RP
    J Pharm Sci; 1964 Jul; 53():714-20. PubMed ID: 14209464
    [No Abstract]   [Full Text] [Related]  

  • 4. NONCLASSICAL ANTIMETABOLITES. XIV. SOME FACTORS IN DESIGN OF IRREVERSIBLE INHIBITORS EFFECTIVE AT LOW CONCENTRATION.
    BAKER BR; PATEL RP; ALMAULA P
    J Pharm Sci; 1963 Nov; 52():1051-7. PubMed ID: 14079630
    [No Abstract]   [Full Text] [Related]  

  • 5. NON-CLASSICAL ANTIMETABOLITES. VII. THE BRIDGE PRINCIPLE OF SPECIFICITY WITH EXO-ALKYLATING IRREVERSIBLE INHIBITORS.
    BAKER BR
    J Med Pharm Chem; 1962 May; 5():654-6. PubMed ID: 14056398
    [No Abstract]   [Full Text] [Related]  

  • 6. NONCLASSICAL ANTIMETABOLITES. XIII. SIMULATION OF THE 5'PHOSPHORIBOSYL MOIETY OF 5'-ADENYLIC ACID AT THE ENZYME LEVEL BY OMEGA-CARBOXYALKYL AND ARALKYL GROUPS ATTACHED TO ADENINE.
    BAKER BR; SACHDEV HS
    J Pharm Sci; 1963 Oct; 52():933-40. PubMed ID: 14076499
    [No Abstract]   [Full Text] [Related]  

  • 7. SPECTROPHOTOMETRIC EFFECT OF SALICYLIC ACID AND SELECTED ANTIRADIATION AGENTS ON CATALASE AND LACTIC DEHYDROGENASE.
    FOYE WO; THIBODEAU PS
    J Pharm Sci; 1964 Oct; 53():1150-3. PubMed ID: 14249425
    [No Abstract]   [Full Text] [Related]  

  • 8. Non-classical antimetabolities. VIII. The bridge principle of specificity with exo-alkylating irreversible inhibitors.
    BAKER BR
    Biochem Pharmacol; 1962 Dec; 11():1155-61. PubMed ID: 13969125
    [No Abstract]   [Full Text] [Related]  

  • 9. NEW CONCEPTS OF THE USE OF INHIBITORS IN CHEMOTHERAPY.
    KAPLAN NO; FRIEDKIN M
    Adv Chemother; 1964; 13():499-522. PubMed ID: 14195201
    [No Abstract]   [Full Text] [Related]  

  • 10. Non-classical antimetabolites. XI. The bridge principle of specificity with exoalkylating irreversible inhibitors. IV. Highly selective inhibition of the substrateidentical enzyme from two different tissues.
    BAKER BR
    Biochem Pharmacol; 1963 Mar; 12():293-5. PubMed ID: 13969124
    [No Abstract]   [Full Text] [Related]  

  • 11. FACTORS IN THE DESIGN OF ACTIVE-SITE-DIRECTED IRREVERSIBLE INHIBITORS.
    BAKER BR
    J Pharm Sci; 1964 Apr; 53():347-64. PubMed ID: 14189924
    [No Abstract]   [Full Text] [Related]  

  • 12. GAMMA-HYDROXYBUTYRATE IN MAMMALIAN BRAIN. REVERSIBLE OXIDATION BY LACTIC DEHYDROGENASE.
    FISHBEIN WN; BESSMAN SP
    J Biol Chem; 1964 Jan; 239():357-61. PubMed ID: 14114866
    [No Abstract]   [Full Text] [Related]  

  • 13. HORMONAL REGULATION OF DEHYDROGENASE ENZYMES OF THE ANTERIOR PITUITARY.
    MCKERNS KW
    Biochim Biophys Acta; 1963 Jul; 73():507-9. PubMed ID: 14068527
    [No Abstract]   [Full Text] [Related]  

  • 14. DEREPRESSION OF ALKALINE PHOSPHATASE SYNTHESIS BY CHLORAMPHENICOL AND CANAVANINE INHIBITION.
    GALLANT J; STAPLETON R
    J Mol Biol; 1964 Apr; 8():442-51. PubMed ID: 14153517
    [No Abstract]   [Full Text] [Related]  

  • 15. THE INHIBITION OF TWO STEROID-ACTIVATED NICOTINAMIDE-ADENINE DINUCLEOTIDE (PHOSPHATE) TRANSHYDROGENASES BY FOLIC ACID AND FOLIC ACID ANTIMETABOLITES.
    MAINWARING WI; WILLIAMS DC
    Biochem J; 1965 Mar; 94(3):773-7. PubMed ID: 14340071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ACTION OF A NEW SARCOMYCIN DERIVATIVE ON MITOCHONDRIAL ENZYMES OF EHRLICH MOUSE ASCITES CELLS.
    ROCCA E; BRUNORI M
    Biochem Pharmacol; 1964 Mar; 13():379-84. PubMed ID: 14157598
    [No Abstract]   [Full Text] [Related]  

  • 17. Potential anticancer agents--L. Non-classical antimetabolites. II. Some factors in the design of exoalkylating enzyme inhibitors, particulary of lactic dehydrogenase.
    BAKER BR; LEE WW; SKINNER WA; MARTINEZ AP; TONG E
    J Med Pharm Chem; 1960 Dec; 2():633-57. PubMed ID: 14448433
    [No Abstract]   [Full Text] [Related]  

  • 18. INHIBITION OF LACTIC DEHYDROGENASE: A NEW APPROACH TO CANCER CHEMOTHERAPY.
    REYNOLDS VH; FLEMING JH; RICHIE RE; FOSTER JH; COLOWICK SP
    Surg Forum; 1963; 14():128-30. PubMed ID: 14064480
    [No Abstract]   [Full Text] [Related]  

  • 19. [ON THE DETERMINATION OF ACTIVE SITES OF CERTAIN ENZYMES. VI. A STUDY OF INHIBITION IN A REVERSIBLE REACTION].
    DOBRY-DUCLAUX A
    Biochim Biophys Acta; 1964 Jul; 89():1-22. PubMed ID: 14213008
    [No Abstract]   [Full Text] [Related]  

  • 20. A HISTOCHEMICAL STUDY OF THE EFFECTS OF AN ANTIMETABOLITE, 6-AMINONICOTINAMIDE, ON THE LUMBAR SPINAL CORD OF THE ADULT RAT.
    SCHOTLAND DL; COWEN D; GELLER LM; WOLF A
    J Neuropathol Exp Neurol; 1965 Jan; 24():97-107. PubMed ID: 14253577
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.